Critical Insights For Oncology Drug Development In Japan And Asia

CMIC group, the largest CRO in Japan with end to end Pharmaceutical Value Creator solutions, held a webinar “Critical Insights for Oncology Drug Development in Japan and Asia” on Oct 2, 2018.

The webinar was presented by experts in CMIC Group, focusing on tips and insights for early phase oncology drug development in Asia: the market trend, development strategy, regulatory requirements and a case study with step-by-step planning to ensure clinical trial success.

Agenda

1. Informative Session

• Market trend in Japan/Asia
• Drug development strategy
• Regulatory requirements in Japan/Asia
• Case Study: Key steps to ensure clinical trial success

2. Q&A session